<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from url=(0042)http://www.aurobindo.com/docs/history.html -->
<HTML><HEAD><TITLE>Aurobindo Pharma</TITLE>
<META http-equiv=Content-Type content="text/html; charset=iso-8859-1">
<STYLE>A:hover {
	FONT-WEIGHT: bold; COLOR: red
}
</STYLE>

<META content="MSHTML 6.00.2800.1106" name=GENERATOR></HEAD>
<BODY vLink=#000080 aLink=#000080 link=#000080 bgColor=#ffffff leftMargin=0 
topMargin=0>
<SCRIPT type=text/javascript>

function Go(){return}

</SCRIPT>

<SCRIPT src="Aurobindo Pharma_files/exmplmenu2_var.js" 
type=text/javascript></SCRIPT>

<SCRIPT src="Aurobindo Pharma_files/menu_com.js" type=text/javascript></SCRIPT>

<DIV align=center>
<CENTER>
<TABLE height=1 cellSpacing=0 cellPadding=0 width=780 border=0>
  <TBODY>
  <TR>
    <TD width=780 height=1>
      <DIV align=center>
      <TABLE cellSpacing=0 cellPadding=0 width=780 border=0>
        <TBODY>
        <TR>
          <TD>
            <DIV align=center>
            <TABLE cellSpacing=0 cellPadding=0 border=0>
              <TBODY>
              <TR>
                <TD><IMG height=45 src="Aurobindo Pharma_files/top1x1.gif" 
                  width=105 border=0></TD>
                <TD><IMG height=45 src="Aurobindo Pharma_files/top1x2.gif" 
                  width=127 border=0></TD>
                <TD><IMG height=45 src="Aurobindo Pharma_files/top1x3.gif" 
                  width=94 border=0></TD>
                <TD><IMG height=45 src="Aurobindo Pharma_files/top1x4.gif" 
                  width=118 border=0></TD>
                <TD><IMG height=45 src="Aurobindo Pharma_files/top1x5.gif" 
                  width=109 border=0></TD>
                <TD><IMG height=45 src="Aurobindo Pharma_files/top1x6.gif" 
                  width=123 border=0></TD>
                <TD><IMG height=45 src="Aurobindo Pharma_files/top1x7.gif" 
                  width=104 border=0></TD></TR>
              <TR>
                <TD vAlign=top background="Aurobindo Pharma_files/top2x1.gif">
                  <DIV align=center>
                  <CENTER>
                  <TABLE cellSpacing=0 cellPadding=0 border=0>
                    <TBODY>
                    <TR>
                      <TD><A href="http://www.aurobindo.com/home.htm"><IMG 
                        height=15 src="Aurobindo Pharma_files/home.gif" width=45 
                        border=0></A></TD></TR></TBODY></TABLE></CENTER></DIV></TD>
                <TD><IMG height=43 src="Aurobindo Pharma_files/top2x2.gif" 
                  width=127 border=0></TD>
                <TD><IMG height=43 src="Aurobindo Pharma_files/top2x3.gif" 
                  width=94 border=0></TD>
                <TD><IMG height=43 src="Aurobindo Pharma_files/top2x4.gif" 
                  width=118 border=0></TD>
                <TD><IMG height=43 src="Aurobindo Pharma_files/top2x5.gif" 
                  width=109 border=0></TD>
                <TD><IMG height=43 src="Aurobindo Pharma_files/top2x6.gif" 
                  width=123 border=0></TD>
                <TD vAlign=top background="Aurobindo Pharma_files/top2x7.gif">
                  <DIV align=left>
                  <TABLE cellSpacing=0 cellPadding=0 border=0>
                    <TBODY>
                    <TR>
                      <TD><A 
                        href="http://www.aurobindo.com/docs/contactus.html"><IMG 
                        height=18 src="Aurobindo Pharma_files/contactus.jpg" 
                        width=84 
              border=0></A></TD></TR></TBODY></TABLE></DIV></TD></TR></TBODY></TABLE></DIV></TD></TR>
        <TR>
          <TD>
            <DIV align=center>
            <TABLE cellSpacing=0 cellPadding=0 border=0>
              <TBODY>
              <TR>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x1.gif" 
                  width=70 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x2.gif" 
                  width=78 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x3.gif" 
                  width=71 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x4.gif" 
                  width=89 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x5.gif" 
                  width=83 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x6.gif" 
                  width=68 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x7.gif" 
                  width=73 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x8.gif" 
                  width=64 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x9.gif" 
                  width=61 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x10.gif" 
                  width=60 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x11.gif" 
                  width=63 border=0></TD></TR></TBODY></TABLE></DIV></TD></TR>
        <TR>
          <TD height=33></TD></TR>
        <TR>
          <TD>
            <DIV align=center>
            <TABLE cellSpacing=0 cellPadding=0 border=0>
              <TBODY>
              <TR>
                <TD><IMG height=8 src="Aurobindo Pharma_files/stip1x1.gif" 
                  width=95 border=0></TD>
                <TD><IMG height=8 src="Aurobindo Pharma_files/stip1x2.gif" 
                  width=95 border=0></TD>
                <TD><IMG height=8 src="Aurobindo Pharma_files/stip1x3.gif" 
                  width=95 border=0></TD>
                <TD><IMG height=8 src="Aurobindo Pharma_files/stip1x4.gif" 
                  width=95 border=0></TD>
                <TD><IMG height=8 src="Aurobindo Pharma_files/stip1x5.gif" 
                  width=95 border=0></TD>
                <TD><IMG height=8 src="Aurobindo Pharma_files/stip1x6.gif" 
                  width=95 border=0></TD>
                <TD><IMG height=8 src="Aurobindo Pharma_files/stip1x7.gif" 
                  width=95 border=0></TD>
                <TD><IMG height=8 src="Aurobindo Pharma_files/stip1x8.gif" 
                  width=95 border=0></TD>
                <TD><IMG height=8 src="Aurobindo Pharma_files/stip1x9.gif" 
                  width=20 border=0></TD></TR></TBODY></TABLE></DIV></TD></TR>
        <TR>
          <TD>
            <DIV align=center>
            <TABLE cellSpacing=0 cellPadding=0 border=0>
              <TBODY>
              <TR>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x1.gif" 
                  width=70 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x2.gif" 
                  width=78 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x3.gif" 
                  width=71 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x4.gif" 
                  width=89 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x5.gif" 
                  width=83 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x6.gif" 
                  width=68 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x7.gif" 
                  width=73 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x8.gif" 
                  width=64 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x9.gif" 
                  width=61 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x10.gif" 
                  width=60 border=0></TD>
                <TD><IMG height=5 src="Aurobindo Pharma_files/line1x11.gif" 
                  width=63 border=0></TD></TR></TBODY></TABLE></DIV></TD></TR>
        <TR>
          <TD></TD></TR></TBODY></TABLE></DIV></TD></TR></TBODY></TABLE></CENTER></DIV>
<DIV align=center>
<CENTER>
<TABLE cellPadding=0 width=741 background="Aurobindo Pharma_files/graph2.jpg" 
border=0>
  <TBODY>
  <TR>
    <TD align=middle height=20></TD></TR>
  <TR align=middle>
    <TD align=middle><SPAN 
      style="mso-bidi-font-size: 12.0pt; mso-fareast-font-family: Times New Roman; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"><B><FONT 
      face=Verdana color=#000080 size=2><IMG height=5 
      src="Aurobindo Pharma_files/hline1.jpg" width=200 border=0> </FONT><FONT 
      face=Arial color=#000080 size=2>COMPANY HISTORY </FONT><FONT face=Verdana 
      color=#000080 size=2><IMG height=5 src="Aurobindo Pharma_files/hline1.jpg" 
      width=200 border=0></FONT></B></SPAN></TD></TR>
  <TR align=middle>
    <TD vAlign=top>
      <DIV align=center>
      <CENTER>
      <TABLE cellSpacing=4 cellPadding=4 width=600 border=0>
        <TBODY>
        <TR>
          <TD>
            <DIV align=center>
            <CENTER>
            <TABLE cellPadding=0 width=600 border=0>
              <TBODY>
              <TR>
                <TD vAlign=top width=300>
                  <DIV align=left>
                  <TABLE cellSpacing=0 cellPadding=0 width=290 border=0>
                    <TBODY>
                    <TR>
                      <TD vAlign=top>
                        <P><FONT face=Arial size=2><B>The Company was born of a 
                        vision. Founded in 1986 by Mr. P.V.Ramaprasad 
                        Reddy,&nbsp;<BR>Mr. K.Nityananda Reddy and a small, 
                        highly committed set of professionals</B>, Aurobindo 
                        Pharma became a public company in 1992. It commenced 
                        operation in 1988-89 with a single unit manufacturing 
                        semi synthetic penicillins (SSPs) at Pondicherry. 
                        <O:P></O:P></FONT></P>
                        <P class=MsoBodyText><FONT face=Arial size=2><SPAN 
                        style="mso-bidi-font-size: 12.0pt">Aurobindo Pharma had 
                        gone public in 1995 by listing its shares in various 
                        stock exchanges in the country. 
                        <O:P></O:P></SPAN></FONT></P>
                        <P class=MsoBodyText><FONT face=Arial size=2><SPAN 
                        style="mso-bidi-font-size: 12.0pt">The Company is the 
                        <B>market leader in the semi-synthetic penicillin 
                        drugs</B>. It has a presence in key therapeutic segments 
                        like SSPs, cephalosporins, antivirals, CNS, 
                        cardio-vascular, gastroenterology, etc.<O:P> 
                        </O:P></SPAN></FONT></P>
                        <P class=MsoBodyText><FONT face=Arial size=2><SPAN 
                        style="mso-bidi-font-size: 12.0pt">Over the years, the 
                        Company has <B>evolved into a knowledge driven 
                        company</B>. It is R&amp;D focused, has a multi product 
                        portfolio with multi country manufacturing facilities 
                        and is becoming a marketing conglomerate across the 
                        world.<SPAN 
                        style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                        </SPAN><O:P></O:P></SPAN></FONT></P>
                        <P><FONT face=Arial size=2><SPAN 
                        style="mso-bidi-font-size: 12.0pt; mso-fareast-font-family: Times New Roman; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">Aurobindo 
                        Pharma created a name for itself in <B>manufacture of 
                        bulk actives, its area of core competence</B>. After 
                        ensuring a firm foundation of cost effective production 
                        capabilities and a clutch of loyal customers, the 
                        Company has entered the high margin speciality generic 
                        formulations segment with a global marketing 
                        network.</SPAN></FONT></P>
                        <P class=MsoBodyText3><FONT face=Arial size=2><SPAN 
                        style="mso-bidi-font-size: 12.0pt"><B>The formulation 
                        business is systematically organised</B> with a 
                        divisional structure, and has a focused team for each 
                        key international market. Aurobindo believes in gaining 
                        volume and market share in every business/segment it 
                        enters.<O:P> </O:P></SPAN></FONT></P>
                        <P><FONT face=Arial size=2>Aurobindo has invested 
                        significant resources in building a mega infrastructure 
                        for APIs and formulations to emerge as a vertically 
                        integrated pharmaceutical company. Aurobindo’s 5 units 
                        for APIs and 4 units for formulations are designed for 
                        the regulated markets.<BR><BR>The Company holds two 
                        product approvals from USFDA for marketing in the USA 
                        and looks forward for more to come in the near 
                        future.</FONT>
                        <P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">The 
                        Company has accelerated the DMF/ANDA filings programme 
                        in its efforts to build a broad product portfolio for 
                        the regulated markets. Cumulatively, the Company has 
                        filed a total of 52 DMFs (Drug Master Files), of which 
                        22 are with US FDA, and 15 in Europe. Approvals from US 
                        FDA have been received for two products.</SPAN>
                        <P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">12 
                        more applications have been filed with EDQM and 
                        approvals for 3 products have been received.</SPAN>
                        <P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">15 
                        Abbreviated New Drug Applications (ANDA) have been 
                        filed, of which 11 are with the US FDA and 4 in European 
                        Union. Approvals for marketing have been received for 
                        three products from the US 
                  FDA.</SPAN></P></TD></TR></TBODY></TABLE></DIV></TD>
                <TD vAlign=top width=300>
                  <DIV align=right>
                  <TABLE height=301 cellPadding=2 width=290 border=0>
                    <TBODY>
                    <TR>
                      <TD height=22>
                        <P align=center><FONT face=Arial size=2><IMG height=108 
                        src="Aurobindo Pharma_files/auro26.gif" width=250 
                        border=0></FONT></P></TD></TR>
                    <TR>
                      <TD height=426>
                        <P class=MsoBodyText><FONT face=Arial size=2><SPAN 
                        style="mso-bidi-font-size: 12.0pt"><BR>The Company has 
                        <B>adopted cost efficient manufacturing processes and 
                        has continuously widened the product portfolio</B>. 
                        Older drugs have been replaced, and new introductions 
                        made to meet the needs of society. There is a constant 
                        up gradation in product list. The Company applies a 
                        premium to remaining contemporary.<O:P> 
                        </O:P></SPAN></FONT></P>
                        <P class=MsoNormal><FONT face=Arial size=2><SPAN 
                        style="mso-bidi-font-size: 12.0pt">The Company has 
                        <B>forayed into custom synthesis business</B> in a big 
                        way and has a dedicated <B>kilo lab</B> to complement 
                        its current infrastructure in manufacturing and 
                        R&amp;D.<O:P> </O:P></SPAN></FONT></P>
                        <P class=MsoBodyText3><FONT face=Arial size=2><SPAN 
                        style="mso-bidi-font-size: 12.0pt">Aurobindo Pharma has 
                        <B>identified international operations as a major engine 
                        of growth</B> and has hence expanded its global network 
                        of marketing and manufacturing operations. Joint 
                        ventures/subsidiaries in China, Brazil and USA, will 
                        further expand its international franchise.<O:P> 
                        </O:P></SPAN></FONT></P>
                        <P><FONT face=Arial size=2>All the key indicators of the 
                        Company confirm the scorching pace of growth. For 
                        instance, the turnover of Aurobindo Pharma has grown by 
                        80 per cent over the last four years (FY 2000 to FY 
                        2004). Net profit grew by a healthy 70 per cent, in the 
                        same period.</FONT> </P>
                        <P><FONT face=Arial size=2><SPAN 
                        style="mso-bidi-font-size: 12.0pt; mso-fareast-font-family: Times New Roman; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">Over 
                        a period, <B>Aurobindo Pharma has become a knowledge 
                        company</B> <B>with strong intellectual property</B>. It 
                        is now positioned to ride the challenges with 
                        strengthened 
                    fundamentals.</SPAN></FONT></P></TD></TR></TBODY></TABLE></DIV></TD></TR></TBODY></TABLE></CENTER></DIV></TD></TR>
        <TR>
          <TD>
            <P align=center><FONT 
            color=#ff0000>__________________________________________________________________________</FONT></P></TD></TR>
        <TR>
          <TD></TD></TR>
        <TR>
          <TD><B><SPAN style="mso-bidi-font-size: 12.0pt"><FONT face=Arial 
            color=#336699 size=2>The milestones achieved and the evolution of 
            the Company can be summarised as follows:<O:P> 
            &nbsp;</FONT></SPAN></B></TD></TR>
        <TR>
          <TD>
            <DIV align=center>
            <TABLE cellPadding=2 width=300 border=0>
              <TBODY>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Vertical integration<O:P> 
                  &nbsp;</FONT></SPAN></TD></TR>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Mergers and Acquisitions<O:P> 
                  &nbsp;</FONT></SPAN></TD></TR>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Broadening of product 
                portfolio</FONT></SPAN></TD></TR>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Broad basing of the Board of 
                  Directors</FONT></SPAN></TD></TR>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Listing of shares on major stock 
                  exchanges</FONT></SPAN></TD></TR>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Thrust on exports<O:P> 
                &nbsp;</FONT></SPAN></TD></TR>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Strong R&amp;D infrastructure<O:P> 
                  &nbsp;</FONT></SPAN></TD></TR>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Expansion into speciality generic 
                  formulations</FONT></SPAN></TD></TR>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Custom Synthesis</FONT></SPAN></TD></TR>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Joint ventures<O:P> 
              &nbsp;</FONT></SPAN></TD></TR>
              <TR>
                <TD align=middle width=30><IMG height=10 
                  src="Aurobindo Pharma_files/bullet8.gif" width=10 border=0></TD>
                <TD width=266><SPAN style="mso-bidi-font-size: 12.0pt"><FONT 
                  face=Arial size=2>Entry into regulated markets<O:P> 
                  &nbsp;</FONT></SPAN></TD></TR></TBODY></TABLE></DIV></TD></TR></TBODY></TABLE></CENTER></DIV></TD></TR>
  <TR>
    <TD vAlign=top>
      <P align=right><FONT face=Arial size=2>&nbsp;<B><A 
      href="http://www.aurobindo.com/docs/history.html#top">Top</A></B></FONT> 
      </P></TD></TR>
  <TR align=middle>
    <TD vAlign=top>
      <P align=center>&nbsp;<FONT 
      color=#ff0000>__________________________________________________________________________</FONT></P></TD></TR>
  <TR align=middle>
    <TD vAlign=top>&nbsp;</TD></TR></TBODY></TABLE></CENTER></DIV></BODY></HTML>
